Lacey McNally to Antibodies, Monoclonal
This is a "connection" page, showing publications Lacey McNally has written about Antibodies, Monoclonal.
Connection Strength
0.251
-
Anti-tumor activity of an anti-DR5 monoclonal antibody, TRA-8, in combination with taxane/platinum-based chemotherapy in an ovarian cancer model. Gynecol Oncol. 2011 Apr; 121(1):193-9.
Score: 0.079
-
Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer. Clin Cancer Res. 2009 Jun 15; 15(12):4058-65.
Score: 0.071
-
Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging. Cancer Res. 2008 Oct 15; 68(20):8369-76.
Score: 0.068
-
Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer. Cell Death Dis. 2017 12 14; 8(12):3217.
Score: 0.032